Transaction

European Bank for Reconstruction and Development's (EBRD) Investment in Ibnsina Pharma's Operations in Egypt for EGP 1.3bn

Announced
29 January 2026
Target
Ibn Sina Pharma Company S.A.E.
Value
$27.7m
Asset class
Private Credit
Type
Debt Financing
Instrument
Term Loan
Lead investors
European Bank for Reconstruction and Development (EBRD)
Investors
European Bank for Reconstruction and Development (EBRD)
Sector
Healthcare / Pharmaceuticals
Markets
Egypt

About the target

Ibnsina Pharma S.A.E. is an Egypt-based supply chain management company specialising in the distribution of pharmaceutical and cosmetic products. Established in 2001 and headquartered in New Cairo, Egypt, the company serves as a link between manufacturers and point-of-sale entities, including pharmacies, hospitals, and wholesalers. It operates a nationwide network of distribution centres and warehouses, utilising a fleet of transport vehicles to ensure coverage across the Egyptian governorates. The company is listed on the Egyptian Exchange (EGX) under the ticker ISPH. As of recent reporting, Ibnsina Pharma commands a significant share of the Egyptian market, distributing products for over 350 suppliers to more than 46,000 clients.

Sources

  1. solarquarter.com
  2. Partner Researchers